Standout Papers

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease 2020 2026 2022 2024276
  1. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease (2020)
    Shorena Janelidze, Erik Stomrud et al. Nature Communications

Immediate Impact

4 from Science/Nature 74 standout
Sub-graph 1 of 18

Citing Papers

Engineered commensals for targeted nose-to-brain drug delivery
2025 Standout
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease
2025 Standout
42 intermediate papers

Works of Clara Theunis being referenced

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
2020 Standout
Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
2013
and 4 more

Author Peers

Author Last Decade Papers Cites
Clara Theunis 553 303 189 14 813
J. K. Blusztajn 585 414 225 17 975
Tanja Fuchsberger 418 257 103 15 747
Ezzat El-Akkad 681 411 223 8 980
Janna Arteaga 438 151 150 15 736
Bianca Van Broeck 672 267 139 25 876
Luis F. Gomez 475 186 127 17 908
Audrey Gray 670 311 205 20 930
Mar Pacheco‐Herrero 403 295 101 22 878
Yunn Chyn Tung 626 366 240 24 934
Bruno Vasconcelos 614 336 184 8 746

All Works

Loading papers...

Rankless by CCL
2026